Emerging issues of the expression profiling technologies for the study of gynecologic cancer

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 3 SUPPL., 2005, Pages 908-918

  Pappa, Kalliopi I ^a   Anagnou, Nicholas P ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

DNA microarrays; Gene expression profiling; Gynecologic cancer; Proteomics

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; EPOTHILONE B; PACLITAXEL; PROTEOME; TAMOXIFEN; TRANSCRIPTOME;

ACCURACY; BIOINFORMATICS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CARCINOGENESIS; CORRELATION ANALYSIS; DNA MICROARRAY; ENDOMETRIUM CARCINOMA; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GYNECOLOGIC CANCER; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN GENOME; METASTASIS; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; UTERINE CERVIX CARCINOMA; UTERUS CANCER; VALIDATION PROCESS;

COMPUTATIONAL BIOLOGY; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENITAL NEOPLASMS, FEMALE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 24644468625     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.01.018     Document Type: Review

References (87)

1. P.A. Lazo The molecular genetics of cervical carcinoma Br J Cancer 80 1999 2008 2018
2. C.H. Chung, P.S. Bernard, and C.M. Perou Molecular portraits and the family tree of cancer Nat Genet 32 2002 533 540
3. W. Alazawi, M. Pett, B. Arch, L. Scott, T. Freeman, and M.A. Stanley Changes in cervical keratinocyte gene expression associated with integration of human papilloma virus 16 Cancer Res 62 2002 6959 6965
4. K.-A. Lee, J.-H. Shim, C.W. Kho, S.G. Park, B.C. Park, and J.-W. Kim Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics Proteomics 4 2004 839 848
5. M. Nees, J.M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C.D. Woodworth Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kB-responsive genes in cervical keratinocytes J Virol 75 2001 4283 4296
6. C.L. Duffy, S.L. Phillips, and A.J. Klingelhutz Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6 Virology 314 2003 196 205
7. F. Thierry, M.A. Benotmane, C. Demeret, M. Mori, S. Teissier, and C. Desaintes A genomic approach reveals a novel mitotic pathway in papillomavirus carcinogenesis Cancer Res 64 2004 895 903
8. Y. Hiray, Y. Kawamata, N. Takeshima, R. Furuta, T. Kitagawa, and T. Kawaguchi Conventional and array-based comparative genomic hybridigation analysis of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix Int J Oncol 24 2004 977 986
9. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papilloma virus infection in young women N Eng J Med 338 1998 423 428
10. S.S. Wang, and A. Hildesheim Chapter 5: Viral and host factors in human papillomavirus persistence and progression J Natl Cancer Inst Monogr 31 2003 35 40
11. S.A. Lee, D. Kang, S.S. Seo, J.K. Jeong, K.Y. Yoo, and Y.T. Jeon Multiple HPV infection in cervical cancer screened by HPVDNAChip Cancer Lett 198 2003 187 192
12. T.C. Park, C.J. Kim, Y.M. Koh, K.H. Lee, J.H. Yoon, and J.H. Kim Human papillomavirus genotyping by the DNA chip in the cervical neoplasia DNA Cell Biol 23 2004 119 125
13. H.J. An, N. Cho, S. Lee, I.H. Kim, C. Lee, and S.J. Kim Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method Cancer 97 2003 1672 1680
14. N.H. Cho, H.J. An, J.K. Jeong, S. Knag, J.W. Kim, and Y.T. Kim Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis Am J Obstet Gynecol 188 2003 56 62
15. F. Alexander-Sefre, H.B. Salvesen, A. Ryan, N. Singh, L.A. Akslen, and N. MacDonald Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis Gynecol Oncol 91 2003 218 225
16. M.-H. Kim, S.-S. Seo, Y.-S. Song, D.-H. Kang, I.-A. Park, and S.-B. Kang Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes Gynecol Oncol 90 2003 83 90
17. G. Narayan, H. Arias-Pulido, S. Koul, H. Vargas, F.F. Zhang, and J. Villela Frequent promoter methylation of CDHI, DAPK, RARB, and HICI genes in carcinoma of cervix uteri: its relationship to clinical outcome Mol Cancer 2 2003 24
18. P. Schram, G. Schwerdtfeger, F. Burkhalter, A. Raggi, D. Schmidt, and T. Ruffalo Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma Am J Pathol 163 2003 985 992
19. O. Kitahara, T. Katagiri, T. Tsunoda, Y. Harima, and Y. Nakamura Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis Neoplasia 4 2002 295 303
20. M.P. Achary, W. Jaggernauth, E. Gross, A. Alfieri, H.P. Klinger, and B. Vikram Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression Cytogenet Cell Genet 91 2000 39 43
21. C. Shim, W. Zhang, C.H. Rhee, and J.H. Lee Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array Clin Cancer Res 4 1998 3045 3050
22. Y. Meng, L. Wei, and J. Wang Monitoring gene expression profile changes in endometrial cancer using cDNA microarray technology Zhonghua Yi Xue Za Zhi 81 2001 665 668
23. Q. Cheng, W.M. Lau, S.K. Tay, S.H. Chew, T.H. Ho, and K.M. Hui Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma Int J Cancer 98 2002 419 426
24. W. Chen, X. Li, W. Fu, Y. Yang, L. Chen, and X. Cheng Study on expression of cell-cycle related genes in subclonal cell lines of human cervical carcinoma Zhonghua Fu Chan Ke Za Zhi 37 2002 168 170
25. J. Dimitroulakos, W.H. Marhin, J. Tokunaga, J. Irish, P. Gullane, and L.Z. Penn Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas Neoplasia 4 2002 337 346
26. M. Matsushima-Nishiu, M. Unoki, K. Ono, T. Tsunoda, T. Minaguchi, and H. Kuramoto Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN Cancer Res 61 2001 3741 3749
27. Y. Chen, C. Miller, R. Mosher, X. Zhao, J. Deeds, and M. Morrissey Identification of cervical cancer markers by cDNA and tissue microarrays Cancer Res 63 2003 1927 1935
28. W.S. Ahn, S.M. Bae, J.M. Lee, S.E. Nomkoong, S.-J. Han, and Y.L. Cho Searching for pathogenic gene function to cervical cancer Gynecol Oncol 93 2004 41 48
29. T. Fujimoto, A. Nishikawa, M. Iwasaki, N. Akutagawa, M. Teramoto, and R. Kudo Gene expression profiling in two morphologically different uterine carcinoma cell lines derived from a single donor using a human cancer cDNA array Gynecol Oncol 93 2004 446 453
30. G. Moreno-Bueno, C. Sanchez-Estevez, R. Cassia, S. Rodriguez-Perales, R. Diaz-Uriarte, and O. Dominguez Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas Cancer Res 63 2003 5697 5702
31. Y.F. Wong, Z.E. Selvanayagam, N. Wei, J. Porter, R. Vittal, and R. Hu Expression genomics of radiotherapy cancer: molecular classification and prediction of radiotherapy response by DNA microarray Clin Cancer Res 9 2003 5486 5492
32. S.E. Ferguson, A.B. Olshen, A. Viale, C.S. Antrey, R.R. Barakat, and J. Boyd Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma Gynecol Oncol 92 2004 719 725
33. D.R. Schwartz, S.L. Kardia, K.A. Shedden, R. Kuick, G. Michailidis, and J.M.G. Taylor Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas Cancer Res 62 2002 4722 4729
34. P.N. Tonin, T.J. Hudson, F. Rodier, M. Bossolasco, P.D. Lee, and J. Novak Microarray analysis of gene expression mirrors the biology of an ovarian cancer model Oncogene 20 2001 6617 6626
35. D.R. Schwartz, R. Wu, S.L. Kardia, A.M. Levin, C.C. Huang, and K.A. Shedden Novel candidate targets of β-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas Cancer Res 63 2003 2913 2922
36. H.S. Shvartsman, K.H. Lu, J. Lee, J. Lillie, M.T. Deavers, and S. Clifford Over-expression of kallikrein 10 in epithelial ovarian carcinomas Gynecol Oncol 90 2003 44 50
37. K.M. Feely, and M. Wells Precursor lesions of ovarian epithelial malignancy Histopathology 38 2001 87 95
38. M.E. Schaner, D.T. Ross, G. Ciaravino, T. Sørlie, O. Troyanskaya, and M. Diehn Gene expression patterns in ovarian carcinomas Mol Biol Cell 14 2003 4376 4386
39. D. Matei, T. Graeber, R.L. Baldwin, B.Y. Karlan, J. Rao, and D.D. Chang Gene expression in epithelial ovarian carcinoma Oncogene 21 2002 6289 6298
40. G.P. Sawiris, C.A. Sherman-Baust, K.G. Becker, C. Cheadle, D. Teichberg, and P.J. Morin Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer Cancer Res 62 2002 2923 2928
41. G.J. Gardner, and M.J. Birrer Ovarian tumors of low malignant potential: can molecular biology solve this enigma? J Natl Cancer Inst 93 2001 1122 1123
42. R.H. Watson, P.J. Neville, W.J. Roy Jr., A. Hitchcock, and I.G. Campbell Loss of heterozygosity of chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis Oncogene 17 1998 207 212
43. J. Fogh, and G. Temple New human tumor cell lines J. Fogh Human tumor cell in vitro 1975 Plenum New York 115 160
44. R.S. Ismail, R.L. Baldwin, J. Fang, D. Browning, B.Y. Karlan, and J.C. Gasson Differential gene expression between normal and tumor-derived ovarian epithelial cells Cancer Res 60 2000 6744 6749
45. D.T. Ross, U. Scherf, M.B. Eisen, C.M. Perou, C. Rees, and P. Spellman Systematic variation in gene expression patterns in human cancer cell lines Nat Genet 24 2000 227 235
46. K.K. Zorn, A.A. Jazaeri, C.S. Awtrey, G.J. Gardner, S.C. Mok, and J. Boyd Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies Clin Cancer Res 9 2003 4811 4818
47. B.Y. Karlan, R.L. Baldwin, F.D. Cirisano, P.W. Mamula, J. Jones, and L.D. Lagasse Secreted ovarian stromal substance inhibits ovarian cell proliferation Gynecol Oncol 59 1995 67 74
48. S.C. Mok, K.K. Wong, R.K. Chan, C.C. Lau, S.W. Tsao, and R.C. Knapp Molecular cloning of differentially expressed genes in human epithelial ovarian cancer Gynecol Oncol 52 1994 247 252
49. J.B. Welsh, P.P. Zarrinkar, L.M. Sapinoso, S.G. Kern, C.A. Behling, and B.J. Monk Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer Proc Natl Acad Sci U S A 98 2001 476 481
50. K. Ono, T. Tanaka, T. Tsunoda, O. Kitahara, C. Kihara, and A. Okamoto Identification of cDNA microarray of genes involved in ovarian carcinogenesis Cancer Res 60 2000 5007 5011
51. C.M. Perou, S.S. Jeffrey, M. van de Rijn, C.A. Ress, M.B. Eisen, and D.T. Ross Distinctive gene expression patterns in human mammary epithelial cells and breast cancers Proc Natl Acad Sci U S A 96 1999 9212 9217
52. D.J. Lockhart, H. Dang, M.C. Byrne, M.C. Follettie, M.V. Gallo, and M.S. Chee Expression monitoring by hybridization to high density oligonucleotide arrays Nat Biotechnol 14 1996 1675 1680
53. V. Shridhar, J. Lee, A. Pandita, S. Itturia, R. Avula, and J. Staub Genetic analysis of early versus late-stage ovarian tumors Cancer Res 61 2001 5895 5904
54. J.M. Lancaster, H.K. Dressman, R.S. Whitaker, L. Havrilesky, J. Gray, and J.R. Marks Gene expression patterns that characterize advanced stage serous ovarian cancers J Soc Gynecol Invest 11 2004 51 59
55. G. Gebauer, M. Rieger, N. Jager, and N. Lang Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors Anticancer Res 19 1999 2509 2511
56. D. Milliken, C. Scotton, S. Raju, F. Balkwill, and J. Wilson Analysis of chemokines receptor expression in ovarian cancer ascites Clin Cancer Res 8 2002 1108 1114
57. J. Bayani, J.D. Brenton, P.F. Macgregor, B. Beheshti, M. Albert, and D. Nallainathan Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization and expression microarrays Cancer Res 62 2002 3466 3476
58. C. Hough, K.R. Cho, A.B. Zonderman, D.R. Schwartz, and D.J. Morin Coordinately up-regulated genes in ovarian cancer Cancer Res 61 2001 3869 3876
59. B.C. Lee, K. Chak, S. Avraham, and H.K. Avraham Microarray analysis of differentially expressed genes associated with human ovarian cancer Int J Oncol 24 2004 847 851
60. K.K. Mantripragada, P.G. Buckley, T. Diaz de Ståhl, and J.P. Dumarski Genomic microarrays in the spotlight Trends Genet 20 2004 87 94
61. D. Stoll, J. Bachmann, M.F. Templin, and T.O. Joos Microarray technology: an increasing variety of screening tools for proteomic research Drug Discov Today Targets 3 2004 24 31
62. J.D. Wulfkuhle, J.A. Aquino, V.S. Calver, D.A. Fishman, G. Coukos, and L.A. Liotta Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays Proteomics 3 2003 2085 2090
63. E.F. Petricoin, and L.A. Liotta Proteomic approaches in cancer risk and response assessment Trends Mol Med 10 2004 59 64
64. V. Espina, K.A. Dettloff, S. Cowherd, E.F. Petricoin, and L.A. Liotta Use of proteomic analysis to monitor responses to biological therapies Expert Opin Biol Ther 4 2004 83 93
65. I.J. Jacobs, and U. Menon Progress and challenges in screening for early detection of ovarian cancer Mol Cell Proteomics 3 2004 355 366
66. E.F. Petricoin, A.M. Ardekani, B.A. Hitt, P.J. Levine, V.A. Fusaro, and S.M. Steinberg Use of proteomic patterns in serum to identify ovarian cancer Lancet 98 2002 895 899
67. J.B. Welsh, L.M. Sapinoso, S.G. Kern, D.A. Brown, T. Liu, and A.R. Bauskin Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc Natl Acad Sci U S A 100 2003 3410 3415
68. L.J. Van't Veer, and B. Weigelt Road map to metastasis Nat Med 9 2003 999 1000
69. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, and C. Cordon-Cardo A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549
70. G. Poste, and I.J. Fidler The pathogenesis of cancer metastasis Nature 283 1980 139 146
71. M.J. van de Vijver, Y.D. He, L.J. van't Veer, H. Dai, A.A.M. Hart, and D.W. Voskuil A gene expression signature as a predictor of survival in breast cancer N Eng J Med 347 2002 1999 2009
72. S. Ramaswamy, K.N. Ross, E.S. Lander, and T.R. Golub A molecular signature of metastasis in primary solid tumors Nat Genet 33 2003 49 54
73. T.R. Adib, S. Henderson, C. Perrett, D. Hewitt, D. Bourmpoulia, and J. Ledermann Predicting biomarkers for ovarian cancer using gene-expression microarrays Br J Cancer 90 2004 686 692
74. J.C. Chang, E.C. Wooten, A. Tsimelzon, S.G. Hilsenbeck, M.C. Gutierrez, and R. Elledge Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer Lancet 362 2003 362 369
75. M. Sugimura, S. Sagae, S. Ishioka, Y. Nishioka, K. Tsukada, and R. Kudo Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxed-resistance clone Oncology 66 2004 53 61
76. D. Khabele, M. Lopez-Jones, W.C. Yang, D. Arango, S.J. Cross, and L.H. Augenlicht Tumor necrosis factor-α related gene response to Epothilone B in ovarian cancer Gynecol Oncol 93 2004 19 26
77. J.D. Brenton, and C. Caldas Predictive cancer genomics - what do we need? Lancet 362 2003 340 341
78. E.E. Ntzani, and J.P. Ioannidis Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment Lancet 362 2003 1439 1441
79. G.L.G. Miklos, and R. Maleszka Microarray reality checks in the context of a complex disease Nat Biotechnol 22 2004 615 621
80. National Cancer Institute. caCORE: The NCICB cancer informatics infrastructure backbone. Available at http://ncicb.nci.nih.gov/core. Accessed July 29, 2003.
81. D. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, and D. Ghosh ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 2004 1 6
82. A. Berchuck, E.S. Iversen, J.M. Lancaster, H.K. Dressman, M. West, and Nevins J.R. Prediction of optimal versus suboptimal cytoreduction of advanced stage serous ovarian cancer with the use of microarrays Am J Obstet Gynecol 190 2004 910 925
83. R. Stears, T. Martinsky, and M. Schena Trends in microarray analysis Nat Med 9 2003 140 145
84. B. van Steensel, and S. Henikoff Epigenomic profiling using microarrays Biotechniques 35 2003 346 357
85. J. Quackenbush Data standards for 'omic' science Nat Biotechnol 22 2004 613 614
86. K. Shedden, J. Taylor, T.J. Giordano, R. Kuick, D.E. Misek, and G. Rennert Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework Am J Pathol 163 2003 1985 1995
87. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, and D. Ghosh Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression Proc Natl Acad Sci U S A 101 2004 9309 9314